Share
Rajiv Patni
Rajiv Patni, MD, has been appointed Senior Advisor to the CEO and Board of Directors
Dr. Patni brings extensive experience from his tenure at Reata Pharmaceuticals, where he played a key role in the approval of Skyclarys for Friedreich’s ataxia and has contributed to the development of multiple FDA-approved therapies.
